https://staging.greybirdventures.com/ https://staging.greybirdventures.com/2017/11/tasso-ceres-nanosciences-george-mason-university-and-the-united-states-army-medical-research-institute-of-infectious-diseases-receive-4-25m-to-develop-a-universal-surveillance-platform-for-infecti/ 2021-12-09T22:17:00+00:00 https://staging.greybirdventures.com/2017/11/the-managers-of-greybird-ventures-partner-with-jf-healthcare-in-china/ 2021-12-09T22:16:51+00:00 https://staging.greybirdventures.com/2015/07/atlas5d-announces-collaboration-with-biogen/ 2021-12-09T22:16:31+00:00 https://staging.greybirdventures.com/2016/02/duis-ante-ligula/ 2021-12-09T22:16:31+00:00 https://staging.greybirdventures.com/2018/05/walking-speeds-of-multiple-sclerosis-patients-as-measured-by-the-echo5d-ambient-measurement-system-showed-strong-agreement-with-two-clinical-gold-standards/ 2021-12-09T22:16:31+00:00 https://staging.greybirdventures.com/2018/01/atlas5ds-ambient-measurement-system-ams-echo5d-selected-to-support-solid-biosciences-gene-transfer-clinical-trial/ 2021-12-09T22:16:31+00:00 https://staging.greybirdventures.com/2015/12/hummingbird-diagnostics-saarland-university-cooperate-on-cancer-detection/ 2021-12-09T22:15:37+00:00 https://staging.greybirdventures.com/2017/11/hummingbird-diagnostics-gmbh-and-saarland-university-collaborate-in-early-disease-detection-based-on-molecular-markers-mirna-experts-sign-framework-agreement/ 2021-12-09T22:15:36+00:00 https://staging.greybirdventures.com/2017/12/bgi-hummingbird-diagnostics-to-develop-mirna-tests-for-neurodegenerative-disorders/ 2021-12-09T22:15:36+00:00 https://staging.greybirdventures.com/2018/10/jorg-debatin-to-chair-the-supervisory-board-of-hummingbird-diagnostics-gmbh-international-healthcare-leader-strengthens-mirna-experts/ 2021-12-09T22:15:36+00:00 https://staging.greybirdventures.com/2019/09/chinese-ai-start-up-beats-stanford-team-in-x-ray-diagnostic-competition/ 2021-12-09T22:14:49+00:00 https://staging.greybirdventures.com/2019/09/chexpert-pr/ 2021-12-09T22:14:21+00:00 https://staging.greybirdventures.com/2019/09/jf-healthcares-ai-technology-is-first-to-beat-radiologists-in-stanford-chest-x-ray-diagnostic-competition/ 2021-12-09T22:13:50+00:00 https://staging.greybirdventures.com/2020/07/press-release-july-2-2020-​new-preprint-demonstrates-a-rapid-and-versatile-method-for-improving-detection-of-sars-cov-2/ 2021-12-09T22:13:33+00:00 https://staging.greybirdventures.com/2021/04/germanys-gna-biosolutions-commercializing-rapid-mdx-instrument-sars-cov-2-test/ 2021-12-09T22:13:08+00:00 https://staging.greybirdventures.com/2021/06/angstrom-bio-raises-3m-in-private-financing/ 2021-12-09T22:12:43+00:00 https://staging.greybirdventures.com/2017/02/ceres-opens-a-round/ 2021-12-09T22:11:56+00:00 https://staging.greybirdventures.com/2019/06/ceres-nanosciences-university-of-virginia-and-george-mason-university-receive-600000-award-from-the-virginia-catalyst-to-develop-a-nanotrap-liquid-biopsy-collection-device-for-cancer-diagnos/ 2021-12-09T22:11:56+00:00 https://staging.greybirdventures.com/2017/02/ceres-receives-award-from-dod/ 2021-12-09T22:11:56+00:00 https://staging.greybirdventures.com/2016/06/ceres-received-980k-dod-award/ 2021-12-09T22:11:56+00:00 https://staging.greybirdventures.com/2020/09/ceres-nanosciences-receives-6-5m-nih-award-to-expand-nanotrap-particle-manufacturing-capacity-for-covid-19-testing/ 2021-12-09T22:11:56+00:00 https://staging.greybirdventures.com/2017/08/ceres-nanosciences-and-innatoss-laboratories-to-launch-the-nanotrap-lyme-antigen-test-in-the-european-union/ 2021-12-09T22:11:56+00:00 https://staging.greybirdventures.com/2017/12/ceres-nanosciences-announces-plans-for-significant-growth-in-prince-william-county-virginia/ 2021-12-09T22:11:56+00:00 https://staging.greybirdventures.com/2018/05/ceres-nanosciences-reaches-product-development-milestone-for-point-of-care-lyme-disease-test-and-closes-on-an-additional-5-5m-of-series-a-funding/ 2021-12-09T22:11:56+00:00 https://staging.greybirdventures.com/2018/08/ceres-nanosciences-point-of-care-nanotrap-lyme-antigen-test-system-granted-breakthrough-device-designation-by-u-s-food-and-drug-administration/ 2021-12-09T22:11:56+00:00 https://staging.greybirdventures.com/2020/02/ceres-nanosciences-receives-225000-nih-sbir-phase-i-grant-to-improve-serum-quality-for-cell-and-tissue-engineering/ 2021-12-09T22:11:56+00:00 https://staging.greybirdventures.com/2021/03/ceres-nanosciences-opens-advanced-particle-manufacturing-plant-in-northern-virginia-to-expand-nanotrap-particle-manufacturing-capacity-for-covid-19-testing/ 2021-12-09T22:11:55+00:00 https://staging.greybirdventures.com/2020/10/ceres-nanosciences-nabs-243k-sbir-grant-to-adapt-sna-capture-tech-for-portable-sequencing/ 2021-12-09T22:11:55+00:00 https://staging.greybirdventures.com/2021/04/nih-awards-ceres-nanosciences-8-2m-for-wastewater-based-covid-19-surveillance/ 2021-12-09T22:11:55+00:00 https://staging.greybirdventures.com/2021/03/ceres-nanosciences-adding-manufacturing-facility-50-jobs-to-improve-covid-19-tests-washington-business-journal/ 2021-12-09T22:11:55+00:00 https://staging.greybirdventures.com/2021/10/angstrom-bio-raises-3m-in-private-financing-2/ 2021-12-09T22:11:02+00:00 https://staging.greybirdventures.com/2021/10/https-www-biospace-com-article-genetika-ceo-talia-cohen-solal-brings-precision-medicine-to-brain-health/ 2021-12-09T22:11:02+00:00 https://staging.greybirdventures.com/2021/11/https-www-biospace-com-article-genetika-ceo-talia-cohen-solal-brings-precision-medicine-to-brain-health-2/ 2021-12-09T22:10:33+00:00